Answers are grounded in this paper and cite their sources.
Demonstrates improved venous thromboembolism prediction following immunotherapy in lung cancer via machine learning, supporting tailored thromboprophylaxis.
Assessing venous thromboembolism (VTE) risk after immunotherapy remains important for lung cancer management. We analyzed 2,300 patients receiving first-line immunotherapy from two centers, randomly assigned to training (70%), validation (15%), and internal test (15%) sets, and included 491 patients from an independent external center for external validation. Five feature-selection methods and five machine-learning algorithms were compared to develop a 6-month VTE prediction model. The Lasso-logistic model showed the best performance, with areas under the curve of 0.692 and 0.728 in the internal and external test sets, respectively, outperforming Khorana, Padua, PROTECHT, ONKOTEV, and COMPASS-CAT scores (all p < 0.05). The high-risk group had a higher cumulative VTE incidence than the low-risk group (12.3% vs. 4.8%, p = 0.006). Shapley additive explanations (SHAP) analysis identified D-dimer and Eastern Cooperative Oncology Group (ECOG) performance status as the most influential predictors, supporting individualized thromboprophylaxis decisions.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: